Skip to main content

Sandercock Brett's Form 4 filing

Resmed Inc (RMD) · filed Aug 23, 2021

Accession no.
0001127602-21-024177
Filed
Aug 23, 2021
Trade date
Aug 20, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.02M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sandercock BrettCIK 0001346064Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 20, 2021ResMed Common StockMOption exerciseAcquired+5,193$57.76+$299,947.6894,979Direct
Aug 20, 2021ResMed Common StockMOption exerciseAcquired+5,543$57.76+$320,163.68100,522Direct
Aug 20, 2021ResMed Common StockSSaleDisposed−10,736$281.73−$3,024,653.2889,786Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 20, 2021ResMed Common StockMOption exerciseDisposed−5,193$0.00$035,543Direct
Aug 20, 2021ResMed Common StockMOption exerciseDisposed−5,543$0.00$030,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)